会员登录 - 用户注册 - 设为首页 - 加入收藏 - 网站地图 【ancient grain in cereal nyt】5 Stocks Analysts Recommend Heading Into 2020!

【ancient grain in cereal nyt】5 Stocks Analysts Recommend Heading Into 2020

时间:2024-09-29 12:21:59 来源:minimal one piece wallpaper 作者:Focus 阅读:263次

Theancient grain in cereal nyt S&P 500 closed out 2019 with another strong month in December. However, analysts remain optimistic on some top stocks heading into 2020. Here’s a look at several stocks analysts recommend.

Vivint Solar Inc (NYSE:

【ancient grain in cereal nyt】5 Stocks Analysts Recommend Heading Into 2020


VSLR

【ancient grain in cereal nyt】5 Stocks Analysts Recommend Heading Into 2020


)

【ancient grain in cereal nyt】5 Stocks Analysts Recommend Heading Into 2020


Vivint shares doubled in 2019, but analysts see more upside ahead in the long-term for Vivint. Of the last 10 analysts to publish research on Vivint, nine gave the stock a bullish rating with an average price target of $9.03, suggesting 18% upside.


Glu Mobile Inc. (NASDAQ:


GLUU


)


Investors have few chances to buy stocks at a discount after the market’s big run in 2019, but Gluu shares are down 24% on the year. Gluu reported disappointing numbers and issued lackluster guidance this year, but Wall Street sees the sell-off as a buying opportunity.


The 10 most recent research reports on the company resulted in nine bullish ratings with an $8.28 average price target, suggesting 35% upside.


Viking Therapeutics Inc (NASDAQ:


VKTX


)


Viking is a clinical-stage biotech stock developing VK2809, a drug used to treat non-alcoholic steatohepatitis (NASH). Analysts are optimistic about VK2809 given there are currently no other treatments for NASH, which could potentially represent a $35 billion per year market.


In fact, Wall Street is so bullish on Viking that all 10 of the most recent analyst ratings for the stock have been bullish with an average price target of $22.75, suggesting 160% upside.


Catalyst Pharmaceuticals Inc (NASDAQ:


CPRX


)


Like Vivint, biotech stock Catalyst Pharmaceuticals more than doubled in 2019, but analysts say the stock may be just getting started. Management recently said its Firdapse treatment for muscle disorder Lambert-Eaton myasthenic syndrome (LEMS) could generate up to $155 million in 2020 revenue, but competition from Jacobus Pharma’s Ruzurgi could create pricing risk in the near-term.


Nine of 10 most recent analysts to publish research on the stock are bullish with an average price target of $6.94, suggesting 73% upside.


Amazon.com, Inc. (NASDAQ:


AMZN


)


Another year has come and gone, and the Amazon train just keeps on rolling down the tracks. Amazon shares gained another 19.9% in 2019, and Wall Street analysts say e-commerce sales and cloud services growth will produce even more upside in 2020.


Amazon has a ton of analyst coverage, and nine out of the last 10 analysts have been bullish on the stock with an average price target of $2,190, suggesting 22% upside.


Benzinga's Take


Wall Street analysts are far from perfect in their stock recommendations and forecasts. However, investors can be slightly more confident when there is a clear consensus among analysts that cover a particular stock.


Story continues


Do you agree with this take? Email


[email protected]


with your thoughts.


Related Links:


10 Worst Performing S&P 500 Stocks Of 2019


10 Best Performing S&P 500 Stocks Of 2019


Latest Ratings for AMZN


Dec 2019


Assumes


Buy


Nov 2019


Initiates Coverage On


Hold


Oct 2019


Maintains


Market Outperform


View More Analyst Ratings for AMZN


View the Latest Analyst Ratings


0


See more from Benzinga


10 Best Performing S&P 500 Stocks Of The Decade


Here's How Much Investing 0 In Amazon Stock Back In 2010 Would Be Worth Today


Gene Munster Talks Tesla's Opportunity, Apple's Valuation, Netflix's Headwinds


© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


View comments


(责任编辑:Comprehensive)

相关内容
  • Global Vision Care Market (2020 to 2025) - Featuring Alcon, Carl Zeiss and Hoya Among Others
  • Kristen Wiig and Ben Affleck to host 'Saturday Night Live'
  • Travis Scott's 28th Birthday Party Had Kylie Jenner Getting a Tattoo, a Slushie Machine, and a Foggy Gas Station
  • Tesla and Akamai Technologies tumble while Cabot Oil rises
  • Italy opens borders ahead of neighbors, beckoning tourists
  • Why the Fed will keenly watch the purchasing managers releases
  • Could The Finning International Inc. (TSE:FTT) Ownership Structure Tell Us Something Useful?
  • BRIEF-Malaysia Airports Holdings Announces Termination Of Agreement For Proposed Disposal
推荐内容
  • State-backed hackers targeting coronavirus workers, US and UK warn
  • GLOBAL MARKETS-Asian shares blindsided by dismal China data
  • Trump to hold news conference on new NAFTA deal on Monday morning
  • Going Green Goblin for 'Spider-Man 2': Dane DeHaan gets into character
  • Why Is Maximus (MMS) Down 12.8% Since Last Earnings Report?
  • Should You Be Impressed By Michael Hill International Limited’s (ASX:MHJ) ROE?